Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

ORAL-PROTECT I: Oral Asepsis Preventing Transmission During Intubation (ORAL-PROTECT I)

21 de junho de 2026 atualizado por: Manfred Blobner, University Hospital Ulm

ORAL-PROTECT I: Oral Asepsis for Preoperative Reduction Of Tracheal Bacterial Establishment, Colonization, and Transmission

Postoperative respiratory complications, such as bacterial pneumonia, are common and serious problems after general anesthesia. They can lead to longer hospital stays, more complications, and increased mortality. One possible cause is that bacteria from the mouth and throat enter the lower airways during tracheal intubation.

The mouth and throat naturally contain many bacteria, including potentially harmful microorganisms. During general anesthesia, coughing and swallowing reflexes are reduced or absent. When a tracheal tube is inserted, secretions from the mouth and throat may be carried into the trachea. The tube may also support the movement of contaminated fluid into the lower airways.

ORAL-PROTECT I is a prospective, randomized, controlled study. It investigates whether simple oral hygiene before surgery can reduce the transfer of bacteria into the trachea during airway management under general anesthesia.

The study includes patients aged 60 years or older undergoing elective surgery under general anesthesia with tracheal intubation. Participants are randomly assigned to an intervention group or a control group. The intervention group performs oral hygiene immediately before anesthesia. This includes brushing the teeth and tongue for about 3 minutes, followed by rinsing and gargling for about 1 minute with a chlorhexidine antiseptic solution. The control group receives standard care without additional oral hygiene.

Oral, pharyngeal, and tracheal swabs will be collected at predefined time points. The primary outcome is based on the perioperative tracheal bacterial load, sampled every 30 minutes and assessed at two hours after induction of anesthesia. The co-primary outcome is based on the oral bacterial load immediately before endotracheal intubation.

Secondary outcomes include changes in oral and tracheal bacterial load over time and identification of the microorganisms detected. The study aims to clarify early bacterial transfer during airway management and to evaluate whether a simple preoperative oral hygiene measure can reduce this process.

Visão geral do estudo

Descrição detalhada

ORAL-PROTECT I is a prospective, randomized, controlled, unblinded, parallel-group trial investigating whether preoperative oral hygiene can reduce early bacterial transmission from the mouth and throat into the trachea during airway management under general anesthesia.

Postoperative respiratory complications, including bacterial pneumonia, are common and clinically relevant adverse events after general anesthesia. They can contribute to increased morbidity, prolonged hospital stay, and mortality. One possible mechanism is the transmission of bacteria from the oral cavity and pharynx into the lower airways during tracheal intubation. The oral cavity and pharynx naturally contain a broad bacterial flora, including potentially pathogenic microorganisms. During general anesthesia, protective swallowing and coughing reflexes are reduced or absent. During tracheal intubation, bacteria-contaminated secretions from the mouth and throat may enter the trachea and lower airways.

The study includes patients aged 60 years or older undergoing elective surgery under general anesthesia with tracheal intubation. Potentially eligible patients are screened before surgery. Patients are screened for eligibility during pre-admission testing and are approached for study participation. On the day of surgery, patients are reassessed for eligibility before randomization to confirm that eligibility criteria are still met. Patients who performed oral hygiene less than four hours before induction are excluded before randomization.

Eligible participants are randomly assigned to either the intervention group or the control group using a REDCap-based randomization tool. Participants in the intervention group undergo supervised oral hygiene immediately before induction of anesthesia, consisting of 3 minutes of tongue and tooth brushing and 1 minute of chlorhexidine gargling. Participants in the control group receive standard clinical care without additional preoperative oral hygiene measures. All other perioperative procedures, including anesthetic management, airway management, surgical care, and postoperative treatment, are at the discretion of the treating anesthesiologist and independent of study participation.

Bacterial load is assessed using swab-based microbiological sampling at predefined time points. Samples are collected from the oral cavity, pharynx, and trachea to describe perioperative bacterial contamination and its development over time. The perioperative tracheal bacterial load is sampled at 30-minute intervals.

Sample handling and microbiological processing follow a standardized operating procedure. This includes uniform transport conditions, timely laboratory processing, neutralization of residual antiseptic activity, serial dilution, plating on appropriate culture media, aerobic incubation, and quantitative colony counting. Samples from both study groups are processed identically to minimize systematic bias and allow reliable comparison of bacterial load. Additional assessments include the intraoperative course of tracheal bacterial load, tracheal bacterial load before extubation, oral bacterial load approximately 24 hours after surgery, and qualitative microbiological characterization of detected bacteria. Adverse events are evaluated after the intervention and anesthesia.

The study aims to provide insight into early perioperative bacterial transmission during airway management and to evaluate whether a simple, low-risk preoperative oral hygiene intervention can influence bacterial contamination of the trachea under general anesthesia.

Tipo de estudo

Intervencional

Inscrição (Estimado)

60

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

  • Nome: Physician on Duty
  • Número de telefone: +49-731-50060043

Locais de estudo

    • Baden-Wurttemberg
      • Ulm, Baden-Wurttemberg, Alemanha, 89081
        • Ulm University Medical Center, Department of Anesthesiology and Intensive Care Medicine
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Age ≥ 60 years
  • Elective surgery under general anesthesia with endotracheal intubation
  • Expected duration of surgery ≥ 2 hours
  • Ability to provide written informed consent

Exclusion Criteria:

  • Systemic antibiotic therapy within 7 days before surgery
  • Planned postoperative systemic antibiotic therapy
  • Known hypersensitivity or allergy to chlorhexidine
  • Pneumonia or clinically relevant respiratory infection within 7 days before surgery
  • Inability to perform the study intervention as intended
  • Preoperative oral hygiene on the day of surgery, less than four hours prior to induction of the general anesthesia

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Sem intervenção: Standard of care
Standard clinical care without additional preoperative oral hygiene or oral decontamination measures before induction of general anesthesia.
Comparador Ativo: Preoperative oral decontamination with chlorhexidine & tooth & tongue brushing
Supervised preoperative oral decontamination immediately before induction of general anesthesia using chlorhexidine for 1 minute & tooth/tongue brushing for 3 minutes
The intervention consists of supervised preoperative oral decontamination performed in the operating room holding/ induction area immediately before induction of general anesthesia. Participants brush their teeth and tongue for 3 minutes, followed by a rinse with chlorhexidine oral antiseptic solution for 1 minute. The intervention is performed right before endotracheal intubation. All other perioperative procedures are at the discretion of the anesthesiologist in the room.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in tracheal bacterial load at 2 hours after anesthesia induction
Prazo: At 2 hours after induction and intubation
The primary outcome is the change in tracheal bacterial load, defined through tracheal swab obtained 2 hours after induction of anesthesia.
At 2 hours after induction and intubation
Change in oral bacterial load
Prazo: Immediately before endotracheal intubation.
The co-primary outcome is the peri-interventional change in oral bacterial load due to the oral hygiene measures obtained through oral swabs immediately before endotracheal intubation.
Immediately before endotracheal intubation.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Intraoperative development of tracheal bacterial load
Prazo: Every 30 minutes intraoperatively from endotracheal intubation until washout of anesthesia prior to extubation.
This secondary outcome assesses the intraoperative development of tracheal bacterial load during the surgery. Serial tracheal samples are collected every 30 minutes until extubation.
Every 30 minutes intraoperatively from endotracheal intubation until washout of anesthesia prior to extubation.
Change of tracheal bacterial load immediately before extubation
Prazo: Immediately before extubation.
This secondary outcome assesses the tracheal bacterial load immediately before extubation.
Immediately before extubation.
Change of oral bacterial load 24 hours postoperatively
Prazo: Approximately 24 hours postoperatively, with a tolerance of ±2 hours.
This secondary outcome assesses the change in oral bacterial load obtained 24 (± 2) hours after surgery.
Approximately 24 hours postoperatively, with a tolerance of ±2 hours.
Qualitative microbiological characterization of bacteria detected in tracheal samples
Prazo: Tracheal swabs are obtained from right after intubation until extubation. For the primary outcome all samples are plated. If Colony Forming Units (CFU) occur on those within 48 hours, characterization will be performed.
Descriptive analysis of colony forming bacteria that were obtained through tracheal swabs.
Tracheal swabs are obtained from right after intubation until extubation. For the primary outcome all samples are plated. If Colony Forming Units (CFU) occur on those within 48 hours, characterization will be performed.
Safety events related to the oral hygiene intervention
Prazo: From the start of the oral hygiene intervention until approximately 24 hours postoperatively.
This secondary outcome assesses safety events potentially related to the preoperative oral hygiene intervention, including oral mucosal irritation, discomfort, intolerance of the mouth rinse, or other adverse events.
From the start of the oral hygiene intervention until approximately 24 hours postoperatively.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

20 de junho de 2026

Conclusão Primária (Estimado)

30 de outubro de 2026

Conclusão do estudo (Estimado)

1 de maio de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

27 de maio de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

21 de junho de 2026

Primeira postagem (Real)

25 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

25 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

21 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • Ethical Committee Number 23/26

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever